Chinese vaccine market competition analysis（中国疫苗市场竞争分析）.doc

Chinese vaccine market competition analysis Vaccines do not know a lot of friends in the Chinese vaccine market is currently the situation at hand in the muddle of doing things, this is not a good habit, because if changes in the environment surrounding the sale, and we used to and in accordance with past sales marketing practices, then, the effect of the vaccine will be greatly reduced sales. Therefore, to understand simple Chinese vaccine necessary environment is necessary. Currently, I believe that SHI Li-chen: Chinese human vaccine from the use, management and sales basically divided into two categories: A class of seedlings, that count with free seedlings, the state plans to purchase, sales practices led by the government, vaccine manufacturers for production and tender, after winning can only be responsible for production and supply. Two types of vaccine: the enterprise-led marketing, sales practices and government regulation during transport. 2006-2008, the global vaccine market has grown rapidly, significantly higher than the level of the pharmaceutical market, beginning in 2004, the domestic vaccine market annual growth rate of 25 percent from 2006 to 2008, jumped from 3.1 billion to 60 billion yuan, compound annual growth rate of 39%, far exceeding the international market in recent years the growth rate of 29% in 2008, the national pharmaceutical industry realized sales income of 866.6 billion yuan, which is equivalent to the domestic vaccine industry, the pharmaceutical industry in sales of 0.7% , far below the world level of 2.5%, showing that China’s vaccine industry, there is still much room for growth. I SHI Li-chen said: perspective from the competitive situation, is basically about the three forces of the Chinese vaccine market sales: The first forces: the national team national team is currently the main force of China’s vaccine market, which is the leader of the Health and Medicines Group. In the Health Group is the largest product